| Lactose (India) Ltd | 144 Cr. | 115 | 247/84.3 | 32.9 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.81 Cr. | 1.99 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 5,091 Cr. | 470 | 479/192 | 114 | 22.8 | 0.14 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 36.5 Cr. | 49.2 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 30.7 Cr. | 21.0 | 29.1/17.0 | 32.0 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 63.9 Cr. | 84.9 | 134/78.9 | 16.9 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 51,163 Cr. | 1,813 | 2,286/1,275 | 38.4 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 372 Cr. | 16.4 | 22.5/10.8 | 22.6 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 814 Cr. | 1,723 | 1,761/635 | 34.7 | 299 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 108 Cr. | 21.6 | 32.0/15.0 | 33.1 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 792 Cr. | 269 | 449/219 | 7.58 | 123 | 0.93 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 14.9 Cr. | 5.97 | 9.28/2.11 | 8.45 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 407 Cr. | 419 | 477/112 | 65.5 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,829 Cr. | 1,108 | 1,584/1,045 | 47.1 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 59.3 Cr. | 0.29 | 1.24/0.29 | 3.90 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 48.6 Cr. | 20.2 | 26.3/6.40 | 50.1 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.84 Cr. | 9.74 | 17.2/9.40 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 178 Cr. | 500 | 896/443 | 9.67 | 563 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 67.6 Cr. | 67.6 | 71.2/26.1 | 173 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,239 Cr. | 1,458 | 2,452/1,345 | 42.6 | 173 | 0.73 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.8 Cr. | 43.4 | 88.7/37.6 | 41.3 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 16.4 Cr. | 6.57 | 6.57/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 18.6 Cr. | 124 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 34.5 Cr. | 63.0 | 63.1/9.41 | 383 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 31.0 Cr. | 41.1 | 80.0/0.00 | 43.7 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.00 Cr. | 20.0 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 11,023 Cr. | 635 | 1,028/464 | 30.7 | 65.3 | 0.19 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 89.2 Cr. | 20.7 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.7 Cr. | 23.0 | 43.7/17.4 | 50.7 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 99,782 Cr. | 2,417 | 3,055/2,115 | 55.1 | 355 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 245 Cr. | 426 | 524/241 | 25.7 | 119 | 1.06 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 56.6 Cr. | 39.4 | 62.6/31.6 | 51.0 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 64,134 Cr. | 1,095 | 1,443/994 | 18.9 | 557 | 0.37 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 127 Cr. | 204 | 303/170 | 185 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 897 Cr. | 89.5 | 123/74.0 | 19.4 | 32.5 | 1.68 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 43.1 Cr. | 33.0 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,171 Cr. | 1,731 | 1,868/754 | 63.3 | 160 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.29 Cr. | 0.65 | 1.45/0.55 | 85.9 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 250 Cr. | 32.6 | 68.0/30.0 | 13.3 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 8.71 Cr. | 14.9 | 25.5/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 140 Cr. | 5.93 | 6.57/2.82 | 325 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 63,232 Cr. | 29,770 | 37,000/25,260 | 43.5 | 1,992 | 1.60 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,536 Cr. | 831 | 972/550 | 28.3 | 220 | 0.60 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 248 Cr. | 89.5 | 90.9/31.3 | 59.7 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,765 Cr. | 1,571 | 1,628/535 | | 104 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,065 Cr. | 1,294 | 1,870/1,045 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 841 Cr. | 254 | 330/154 | 19.6 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 586 Cr. | 438 | 568/270 | 12.5 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,302 Cr. | 470 | 950/455 | 26.4 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,616 Cr. | 1,146 | 1,616/991 | 22.9 | 768 | 0.87 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,21,817 Cr. | 3,596 | 3,790/2,886 | 60.3 | 224 | 0.89 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,161 Cr. | 126 | 317/98.0 | | 43.7 | 0.40 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,560 Cr. | 16.6 | 24.0/14.1 | 27.4 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 32,504 Cr. | 850 | 1,360/848 | 92.4 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,463 Cr. | 196 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,06,208 Cr. | 1,694 | 1,924/1,547 | 35.4 | 301 | 0.94 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,654 Cr. | 591 | 886/441 | 108 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,651 Cr. | 300 | 319/175 | 37.7 | 75.9 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 338 Cr. | 1,120 | 1,680/956 | 19.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 7,255 Cr. | 370 | 502/265 | 56.4 | 121 | 0.13 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,118 Cr. | 204 | 232/111 | 170 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,801 Cr. | 4,694 | 6,899/4,146 | 30.3 | 340 | 2.49 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,935 Cr. | 2,381 | 2,776/1,772 | 35.3 | 335 | 0.84 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 10,201 Cr. | 6,160 | 6,739/4,863 | 33.9 | 323 | 2.03 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 179 Cr. | 50.7 | 87.5/32.5 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 24,313 Cr. | 5,309 | 5,993/3,701 | 36.0 | 922 | 0.66 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 127 Cr. | 103 | 348/81.0 | 8.97 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,683 Cr. | 439 | 582/281 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,620 Cr. | 714 | 1,998/604 | 42.5 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 20,326 Cr. | 15,798 | 18,100/10,060 | 154 | 1,188 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 316 Cr. | 14.3 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,792 Cr. | 825 | 1,505/660 | 8.71 | 425 | 0.73 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,653 Cr. | 48.5 | 91.7/41.7 | 28.6 | 21.1 | 0.41 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,063 Cr. | 178 | 359/162 | 23.0 | 54.4 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 107 Cr. | 68.0 | 130/65.5 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 337 Cr. | 94.2 | 177/90.2 | 44.9 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 87,821 Cr. | 1,923 | 2,403/1,774 | 23.7 | 377 | 0.62 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,055 Cr. | 526 | 980/499 | 12.2 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 50,815 Cr. | 940 | 956/460 | 74.4 | 91.1 | 0.13 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 939 Cr. | 905 | 1,235/596 | 21.6 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 151 Cr. | 69.2 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 805 Cr. | 167 | 327/154 | 23.0 | 107 | 1.80 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 699 Cr. | 400 | 500/265 | 25.0 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,915 Cr. | 1,124 | 1,310/802 | 36.9 | 393 | 0.44 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,634 Cr. | 1,701 | 1,998/1,303 | 38.9 | 221 | 0.91 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,435 Cr. | 216 | 328/179 | 33.7 | 36.1 | 1.16 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 32,952 Cr. | 1,298 | 1,758/1,168 | 36.8 | 274 | 0.31 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,734 Cr. | 93.1 | 127/57.5 | 26.0 | 57.5 | 0.86 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 761 Cr. | 104 | 124/67.2 | 34.5 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,544 Cr. | 277 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,994 Cr. | 243 | 465/236 | 47.3 | 102 | 0.58 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,401 Cr. | 1,647 | 2,786/1,243 | 37.3 | 369 | 0.43 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,369 Cr. | 336 | 504/285 | 55.1 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,805 Cr. | 566 | 628/412 | 28.9 | 153 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 51,163 Cr. | 1,813 | 2,286/1,275 | 38.4 | 314 | 0.14 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 45,648 Cr. | 2,687 | 3,516/1,921 | 48.2 | 115 | 1.56 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 31,631 Cr. | 1,918 | 2,131/1,200 | 27.8 | 592 | 0.94 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 7,029 Cr. | 432 | 559/359 | 26.1 | 140 | 1.16 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 22,184 Cr. | 1,628 | 1,910/1,097 | 57.3 | 210 | 0.45 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,07,156 Cr. | 1,284 | 1,406/1,020 | 18.6 | 432 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,598 Cr. | 293 | 322/170 | 38.7 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,28,003 Cr. | 1,584 | 1,673/1,310 | 23.7 | 386 | 0.82 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 15,261 Cr. | 2,016 | 2,641/1,551 | 27.0 | 347 | 0.30 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 329 Cr. | 112 | 203/95.6 | 162 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,598 Cr. | 151 | 191/105 | 15.0 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 63.1 Cr. | 38.9 | 73.3/38.0 | 22.6 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 48,238 Cr. | 360 | 406/291 | 133 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,853 Cr. | 1,836 | 2,215/1,430 | 40.5 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 131 Cr. | 81.9 | 141/76.3 | 18.3 | 48.6 | 1.46 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 314 Cr. | 133 | 179/67.8 | 31.2 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 23,309 Cr. | 9,312 | 10,691/6,220 | 110 | 308 | 0.34 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,086 Cr. | 720 | 843/544 | 38.2 | 113 | 0.64 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 188 Cr. | 89.7 | 137/85.0 | 7.14 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 65,457 Cr. | 5,476 | 6,084/4,492 | 28.8 | 1,002 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 18,001 Cr. | 915 | 1,156/725 | 30.4 | 264 | 1.20 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 461 Cr. | 808 | 1,540/763 | 73.2 | 688 | 0.62 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 29,911 Cr. | 2,393 | 3,181/2,022 | 32.2 | 303 | 1.17 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,381 Cr. | 302 | 509/258 | 24.7 | 127 | 1.72 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,515 Cr. | 491 | 575/312 | 25.2 | 136 | 0.20 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,820.13 Cr | 1,181.71 | | 50.30 | 194.36 | 0.34% | 16.24% | 14.95% | 6.10 |